Table 2.
Methodological score of randomized clinical trials using the Physiotherapy Evidence Database (PEDro) scale
| Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baumann FT. et al. 2010 | Y | Y | N | N | N | N | N | Y | N | Y | Y | 4/11 |
| Dimeo et al., 1999 | Y | Y | N | Y | N | N | N | Y | Y | Y | Y | 6/11 |
| McCourt et al., 2023 | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 7/11 |
| Potiaumpai M. et al. 2024 | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 7/11 |
| Santa Mina D. et al. 2020 | Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 6/11 |
| Wiskemann J. et al. 2010 | Y | Y | N | Y | N | N | N | N | Y | Y | Y | 5/11 |
| Van Haren et al., 2018 | Y | N | N | N | N | N | N | N | Y | Y | Y | 3/11 |
Y = yes; N = no.
1: eligibility criteria; 2: random allocation of participants; 3: concealed allocation; 4: similarity between groups at baseline; 5: participant blinding; 6: therapist blinding; 7: assessor blinding; 8: dropout rate less than 15%; 9: intention-to-treat analysis; 10: between-group statistical comparisons; 11: point measures and variability data